speb/financial-data huggingface dataset:
Financial ratios for CHC.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.030075187969924
Shares outstanding: 472857936
Market cap (USD): 4742800651.30827
Buyback yield (%): 0.3249880180043988
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHC.AX — annual report dated 2022-06-30
Total revenue: 707379310.3448277
Gross profit: 707379310.3448277
Operating income: 344068965.5172414
Net income: 639310344.8275862
Capital expenditures: 7655172.413793104
Depreciation & amortization: 6275862.068965517
Net tangible assets: 2160344827.586207
Owner earnings: 637931034.4827586
Return on net tangible assets (%): 29.52913008778931
Capex to operating income (%): 2.2248947684906795
Buffett classification: The Great
Stock price: 6.6000000000000005
P/E ratio: 4.881607818252428
Shares outstanding: 472857936
Book value: 2268758620.6896553
P/B ratio: 1.3755814960391524
Market cap (USD): 3120862377.6000004
Debt to equity: 0.1460011551205277
Current ratio: 2.4318849089841454
Quick ratio: 2.4318849089841454
Effective tax rate (%): 16.21475054229935
Interest coverage ratio: 33.260000000000005
COGS to revenue (%): 0
SG&A to revenue (%): 20.522569952227744
Free cash flow (dilution-adjusted): 408758620.6896552
Buyback yield (%): 0
Retained earnings: 968206896.5517242
Receivables turnover: 8.888214904679376
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.951713395638627
FCF margin (%): 57.784927366676406
Rule of 40 score: 57.784927366676406
Financial ratios for CHC.AX — annual report dated 2023-06-30
Total revenue: 520132450.3311258
Gross profit: 520132450.3311258
Operating income: 235562913.90728477
Net income: 129867549.66887417
Capital expenditures: 1523178.8079470198
Depreciation & amortization: 5761589.40397351
Net tangible assets: 2080596026.4900663
Owner earnings: 134105960.26490067
Return on net tangible assets (%): 6.445554954324092
Capex to operating income (%): 0.64661231374754
Buffett classification: The Great
Stock price: 6.503311258278146
P/E ratio: 23.679066453442122
Shares outstanding: 472857936
Book value: 2155761589.4039736
P/B ratio: 1.4264760787417055
Market cap (USD): 3075142338.7549667
Debt to equity: 0.1456746129270091
Current ratio: 2.246694370986022
Quick ratio: 2.246694370986022
Effective tax rate (%): 39.061528899937855
Interest coverage ratio: 13.223048327137548
COGS to revenue (%): 0
SG&A to revenue (%): 27.667430608607084
Free cash flow (dilution-adjusted): 221854304.6357616
Buyback yield (%): 0.19166721685753443
Retained earnings: 926688741.7218543
Receivables turnover: 4.924137931034482
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.341106646708159
FCF margin (%): 42.653425006366184
Revenue growth (%): -26.470502780527216
Rule of 40 score: 16.18292222583897
Financial ratios for CHC.AX — annual report dated 2024-06-30
Total revenue: 331533333.3333333
Gross profit: 331533333.3333333
Operating income: 147666666.66666666
Net income: -148066666.66666666
Capital expenditures: 1666666.6666666667
Depreciation & amortization: 8000000
Net tangible assets: 1805066666.6666667
Owner earnings: -141733333.3333333
Return on net tangible assets (%): -7.851972226325896
Capex to operating income (%): 1.1286681715575624
Buffett classification: The Great
Stock price: 7.093333333333334
Shares outstanding: 472857936
Book value: 1880400000
P/B ratio: 1.7837369492448416
Market cap (USD): 3354138959.36
Debt to equity: 0.16822661844997516
Current ratio: 2.100220264317181
Quick ratio: 2.100220264317181
Interest coverage ratio: 6.671686746987952
COGS to revenue (%): 0
SG&A to revenue (%): 42.89161471948522
Free cash flow (dilution-adjusted): 283666666.6666667
Buyback yield (%): 0.22261053454062543
Retained earnings: 642666666.6666666
Receivables turnover: 4.718216318785578
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.570165811408062
FCF margin (%): 85.56203498894028
Revenue growth (%): -36.25982514217808
Rule of 40 score: 49.3022098467622
Financial ratios for CIA.TO — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.008
Shares outstanding: 560046922
Market cap (USD): 2804714985.376
Buyback yield (%): 4.959425292272783
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIA.TO — annual report dated 2023-03-31
Total revenue: 954742953.0201342
Gross profit: 302873825.5033557
Operating income: 248628187.9194631
Net income: 134702684.5637584
Capital expenditures: 196113422.81879196
Operating cash flow: 158378523.4899329
Depreciation & amortization: 81237583.89261745
Net tangible assets: 842173154.3624161
Owner earnings: 19826845.63758388
Return on net tangible assets (%): 2.3542481180837673
Capex to operating income (%): 78.87819336169478
Buffett classification: The Gruesome
Stock price: 4.377777777777777
P/E ratio: 18.201277707156308
Shares outstanding: 560046922
Book value: 847452348.9932885
P/B ratio: 2.8930959629257704
Market cap (USD): 2451760969.644444
Debt to equity: 0.44517321557546347
Current ratio: 3.5885742348948257
Quick ratio: 2.7732886637038194
Effective tax rate (%): 42.083423509212366
Interest coverage ratio: 26.295854628052243
COGS to revenue (%): 66.34527582883618
R&D to revenue (%): 0.8339150282552598
SG&A to revenue (%): 3.5716419683572025
Free cash flow (dilution-adjusted): -45195973.15436242
Buyback yield (%): 0
Retained earnings: 547589261.7449664
Inventory turnover: 5.628949722669529
Receivables turnover: 7.106439204715755
Capitalized R&D asset: 7961744.966442953
ROCI (R&D-adjusted, %): 17.83498957171602
FCF margin (%): -4.733836789409568
Rule of 40 score: -4.733836789409568
Financial ratios for CIA.TO — annual report dated 2024-03-31
Total revenue: 1035652941.1764705
Gross profit: 337704575.1633987
Operating income: 279681699.3464052
Net income: 153066013.07189542
Capital expenditures: 222324183.00653595
Operating cash flow: 310186274.5098039
Depreciation & amortization: 80773856.20915033
Net tangible assets: 909371241.8300654
Owner earnings: 11515686.274509788
Return on net tangible assets (%): 1.266334995522294
Capex to operating income (%): 79.49185932654535
Buffett classification: The Gruesome
Stock price: 4.419117647058823
P/E ratio: 16.168927291708478
Shares outstanding: 560046922
Book value: 912751633.9869282
P/B ratio: 2.7114859552545267
Market cap (USD): 2474913236.1911764
Debt to equity: 0.44139032301952713
Current ratio: 2.786133698165419
Quick ratio: 1.7566045853697794
Effective tax rate (%): 40.38317121786435
Interest coverage ratio: 10.973253667042773
COGS to revenue (%): 63.58945037357633
R&D to revenue (%): 0.7150930643356564
SG&A to revenue (%): 3.765866502077247
Free cash flow (dilution-adjusted): 80951633.9869281
Buyback yield (%): 0
Retained earnings: 618716339.869281
Inventory turnover: 3.029382672250767
Receivables turnover: 13.195887707259388
Capitalized R&D asset: 12740251.480457954
ROCI (R&D-adjusted, %): 18.080950000085018
Rosenberg metric: 4.374763297097199
FCF margin (%): 7.816482797313305
Revenue growth (%): 8.47453106623035
Rule of 40 score: 16.291013863543654
Financial ratios for CIA.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.681481481481481
Shares outstanding: 560046922
Market cap (USD): 2621849294.1037035
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIA.TO — quarterly report dated 2024-12-31
Total revenue: 236383229.8136646
Gross profit: 42286335.403726704
Operating income: 31349068.322981365
Net income: 1081366.4596273291
Capital expenditures: 118952173.91304347
Operating cash flow: -4001863.3540372667
Depreciation & amortization: 22584472.04968944
Net tangible assets: 863822981.3664596
Owner earnings: -95286335.4037267
Return on net tangible assets (%): -11.030771056009145
Capex to operating income (%): 379.4440481851324
Buffett classification: The Gruesome
Stock price: 3.5104895104895104
P/E ratio: 454.52649921759456
Shares outstanding: 560046922
Book value: 867242236.0248448
P/B ratio: 2.267000802537728
Market cap (USD): 1966038845.062937
Debt to equity: 0.5788900348072707
Current ratio: 2.2809144636282888
Quick ratio: 1.1429728228289493
Effective tax rate (%): 91.84428725347824
Interest coverage ratio: 6.468281430219146
COGS to revenue (%): 77.53726578327118
R&D to revenue (%): 0.5730771959419514
SG&A to revenue (%): 2.8191404104819786
Free cash flow (dilution-adjusted): -123052173.91304347
Buyback yield (%): 0
Retained earnings: 587516770.1863353
Inventory turnover: 0.8138971709744237
Receivables turnover: 1.758576234219914
Capitalized R&D asset: 1354658.3850931677
ROCI (R&D-adjusted, %): 1.9707989580870278
FCF margin (%): -52.05621989768168
Rule of 40 score: -52.05621989768168
Financial ratios for CIA.TO — annual report dated 2025-03-31
Total revenue: 1014840880.5031446
Gross profit: 252661635.22012576
Operating income: 200499371.06918237
Net income: 89336477.98742138
Capital expenditures: 379867924.5283019
Operating cash flow: 191206289.3081761
Depreciation & amortization: 93461635.22012578
Net tangible assets: 899483647.798742
Owner earnings: -197069811.32075474
Return on net tangible assets (%): -21.909215559730637
Capex to operating income (%): 189.46090578869115
Buffett classification: The Gruesome
Stock price: 2.979020979020979
P/E ratio: 18.675367189974025
Shares outstanding: 560046922
Book value: 902766037.735849
P/B ratio: 1.8480884970578615
Market cap (USD): 1668391529.874126
Debt to equity: 0.5570831225903895
Current ratio: 2.0416552823949905
Quick ratio: 1.0449813483810173
Effective tax rate (%): 46.42783059962963
Interest coverage ratio: 9.823252087634424
COGS to revenue (%): 74.66839613608602
R&D to revenue (%): 0.5285086672818554
SG&A to revenue (%): 3.4296667631385036
Free cash flow (dilution-adjusted): -193066037.73584905
Buyback yield (%): 0
Retained earnings: 619523270.4402516
Inventory turnover: 3.3703051002967923
Receivables turnover: 7.846593368118536
Capitalized R&D asset: 12952839.027975377
ROCI (R&D-adjusted, %): 11.750412100029951
Rosenberg metric: -11.483161072562666
FCF margin (%): -19.024266901834842
Revenue growth (%): -2.0095593654843507
Rule of 40 score: -21.033826267319192
Financial ratios for CIA.TO — quarterly report dated 2025-03-31
Total revenue: 267512578.6163522
Gross profit: 65569182.3899371
Operating income: 52757232.704402514
Net income: 24616352.201257862
Capital expenditures: 69461006.28930818
Operating cash flow: 90803773.58490565
Depreciation & amortization: 26739622.641509432
Net tangible assets: 899483647.798742
Owner earnings: -18105031.446540877
Return on net tangible assets (%): -2.012824968063438
Capex to operating income (%): 131.6615802775261
Buffett classification: The Gruesome
Stock price: 2.979020979020979
P/E ratio: 16.943935440085976
Shares outstanding: 560046922
Book value: 902766037.735849
P/B ratio: 1.8480884970578615
Market cap (USD): 1668391529.874126
Debt to equity: 0.5570831225903895
Current ratio: 2.0416552823949905
Quick ratio: 1.0449813483810173
Effective tax rate (%): 47.565844117568254
Interest coverage ratio: 10.424257487262334
COGS to revenue (%): 75.48930867883719
R&D to revenue (%): 0.6822696869599971
SG&A to revenue (%): 3.0457628513324475
Free cash flow (dilution-adjusted): 21662893.081761003
Buyback yield (%): 0
Retained earnings: 619523270.4402516
Inventory turnover: 0.8981814825071541
Receivables turnover: 2.0683660518471334
Capitalized R&D asset: 2732778.3507168246
ROCI (R&D-adjusted, %): 3.180307145028193
Rosenberg metric: 17.187246055845367
FCF margin (%): 8.0978970012578
Revenue growth (%): 13.169017458313839
Rule of 40 score: 21.266914459571638
Financial ratios for CIA.TO — quarterly report dated 2025-06-30
Total revenue: 272273856.2091503
Gross profit: 19152287.581699345
Operating income: 6467973.8562091505
Net income: 15545098.039215686
Capital expenditures: 74637254.90196079
Operating cash flow: 53027450.98039216
Depreciation & amortization: 30585620.915032677
Net tangible assets: 939653594.7712418
Owner earnings: -28506535.94771243
Return on net tangible assets (%): -3.0337281851885356
Capex to operating income (%): 1153.9510913500403
Buffett classification: The Gruesome
Stock price: 2.6715328467153285
P/E ratio: 36.277438534433514
Shares outstanding: 560046922
Book value: 942909803.9215685
P/B ratio: 1.5867729252598486
Market cap (USD): 1496183747.8248177
Debt to equity: 0.5895156974793644
Current ratio: 1.8319685653438915
Quick ratio: 0.9852452355826783
Effective tax rate (%): 1.7717754925040268
Interest coverage ratio: 1.2978360655737706
COGS to revenue (%): 86.59197895237158
R&D to revenue (%): 0.44913449789835785
SG&A to revenue (%): 2.9439794132685515
Free cash flow (dilution-adjusted): -21732679.73856209
Buyback yield (%): 0
Retained earnings: 624510457.5163399
Inventory turnover: 1.1616846688436742
Receivables turnover: 3.1945507388633696
Capitalized R&D asset: 2892768.429986159
ROCI (R&D-adjusted, %): 0.3529229252899997
Rosenberg metric: -25.431723895623033
FCF margin (%): -7.981919395840883
Revenue growth (%): 1.7798331642664194
Rule of 40 score: -6.202086231574464
Financial ratios for CIA.TO — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.0431654676259
P/E ratio: 41.32393443623377
Shares outstanding: 560046922
Market cap (USD): 1704315453.280576
Buyback yield (%): 0
Capitalized R&D asset: 1421628.6841780737
Rule of 40 score: 0
Financial ratios for CIA.TO — quarterly report dated 2025-12-31
Total revenue: 316985906.0402685
Gross profit: 93789261.74496645
Operating income: 73980536.91275167
Net income: 43605369.12751678
Capital expenditures: 59235570.46979866
Operating cash flow: 54840939.59731544
Depreciation & amortization: 30101342.281879194
Net tangible assets: 1010590604.0268457
Owner earnings: 14471140.939597301
Return on net tangible assets (%): 1.4319488902761346
Capex to operating income (%): 80.069127559398
Buffett classification: The Gruesome
Stock price: 3.9854014598540144
P/E ratio: 26.64553623219533
Shares outstanding: 560046922
Book value: 1013301342.281879
P/B ratio: 2.2027127838390337
Market cap (USD): 2232011820.5255475
Debt to equity: 0.7024789064119608
Current ratio: 2.563227796116354
Quick ratio: 1.6834968307840128
Effective tax rate (%): 38.38947049006221
Interest coverage ratio: 9.788739898765652
COGS to revenue (%): 70.41216661126506
R&D to revenue (%): 0.5301613985759323
SG&A to revenue (%): 4.549775676516856
Free cash flow (dilution-adjusted): -8964429.530201342
Buyback yield (%): 0
Retained earnings: 687209395.9731544
Inventory turnover: 1.171689591025677
Receivables turnover: 1.8064085549389397
Capitalized R&D asset: 2084085.932359521
ROCI (R&D-adjusted, %): 3.5790363058321346
FCF margin (%): -2.8280214859339963
Rule of 40 score: -2.8280214859339963
Financial ratios for DEFT — quarterly report dated 2024-09-30
Operating income: 10695381.481481481
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.09
Shares outstanding: 387895989
Market cap (USD): 810702617.01
Buyback yield (%): 0.04764518241785523
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEFT — annual report dated 2024-12-31
Total revenue: 48857669.93006993
Gross profit: 27946072.72727273
Operating income: -15517716.083916085
Net income: -19952583.916083917
Capital expenditures: 0
Operating cash flow: -66351956.64335664
Depreciation & amortization: 1083905.5944055945
Net tangible assets: -13750246.153846154
Owner earnings: -18868678.32167832
Buffett classification: The Gruesome
Stock price: 2.72
Shares outstanding: 387895989
Book value: 13387550.349650383
P/B ratio: 78.81031723683141
Market cap (USD): 1055077090.08
Debt to equity: 0.5063306651096401
Current ratio: 0.7904782511592561
Quick ratio: 0.7904782511592561
Interest coverage ratio: -7.857511015930076
COGS to revenue (%): 42.80105300299423
SG&A to revenue (%): 42.26043028252123
Free cash flow (dilution-adjusted): -79813274.82517482
Buyback yield (%): 0.20988152514466815
Retained earnings: -114299322.37762238
Receivables turnover: 1.8091329607233873
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -115.91154228093217
FCF margin (%): -163.35874170710903
Revenue growth (%): 337.0316289158792
Rule of 40 score: 173.67288720877016
Financial ratios for DEFT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.72
Shares outstanding: 387895989
Market cap (USD): 1055077090.08
Buyback yield (%): 0.10291903909266645
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEFT — quarterly report dated 2025-03-31
Total revenue: 16309379.020979023
Gross profit: 14097486.013986014
Operating income: 21123002.0979021
Net income: 20978895.104895107
Capital expenditures: 0
Operating cash flow: -38136460.13986014
Depreciation & amortization: 260923.77622377622
Net tangible assets: 10985527.741258742
Owner earnings: 21239818.881118882
Return on net tangible assets (%): 193.34363702298734
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.24
P/E ratio: 10.354299058834352
Shares outstanding: 387895989
Book value: 38949992.02097893
P/B ratio: 22.30775849432799
Market cap (USD): 868887015.3600001
Debt to equity: 0.15765162865795496
Current ratio: 0.9692739952930083
Quick ratio: 0.9692739952930083
Effective tax rate (%): 2.4277805127073613
Interest coverage ratio: 254.2819032065259
COGS to revenue (%): 13.562092119803044
SG&A to revenue (%): 40.451180606877195
Free cash flow (dilution-adjusted): -41713528.67132867
Buyback yield (%): 0
Retained earnings: -87327360.39860141
Receivables turnover: 0.381813702561265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 54.23108196408616
FCF margin (%): -255.76405219151428
Rule of 40 score: -255.76405219151428
Financial ratios for DEFT — quarterly report dated 2025-06-30
Total revenue: 19747255.47445255
Gross profit: 15408856.934306568
Operating income: -452620.43795620435
Net income: -940275.912408759
Capital expenditures: 0
Operating cash flow: -11238566.423357664
Depreciation & amortization: 243195.62043795618
Net tangible assets: 18993942.335766423
Owner earnings: -697080.2919708028
Return on net tangible assets (%): -3.670013732000071
Buffett classification: The Gruesome
Stock price: 2.93
P/E ratio: 56.717243680949515
Shares outstanding: 387895989
Book value: 50257528.46715319
P/B ratio: 22.61422880181633
Market cap (USD): 1136535247.77
Debt to equity: 0.10757589370276156
Current ratio: 0.8659154461576732
Quick ratio: 0.8659154461576732
Interest coverage ratio: -5.380250405629355
COGS to revenue (%): 21.96962785921651
SG&A to revenue (%): 27.300554378063808
Free cash flow (dilution-adjusted): -13746192.700729925
Buyback yield (%): 0
Retained earnings: -98347729.19708028
Receivables turnover: 0.37168997614602317
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.900602261513961
FCF margin (%): -69.61064902671498
Revenue growth (%): 21.07913764865806
Rule of 40 score: -48.53151137805692
Financial ratios for DEFT — quarterly report dated 2025-09-30
Total revenue: 16360096.4028777
Gross profit: 15056324.460431656
Operating income: 6658787.769784173
Net income: 2899262.589928058
Capital expenditures: 0
Operating cash flow: -31074728.77697842
Depreciation & amortization: 367291.36690647487
Net tangible assets: 54126552.51798561
Owner earnings: 3266553.956834533
Return on net tangible assets (%): 6.035030506975473
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.11
P/E ratio: 35.681609337505705
Shares outstanding: 387895989
Book value: 84689184.89208627
P/B ratio: 9.664286388314034
Market cap (USD): 818460536.79
Debt to equity: 0.13630147894076367
Current ratio: 0.8770465678406494
Quick ratio: 0.8770465678406494
Effective tax rate (%): 11.116285077838342
Interest coverage ratio: 65.40679103950251
COGS to revenue (%): 7.969219192478065
SG&A to revenue (%): 48.1287686560043
Free cash flow (dilution-adjusted): -32675344.604316548
Buyback yield (%): 0.049904622388967985
Retained earnings: -94033391.36690648
Receivables turnover: 0.1391271194523209
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.68688464566694
FCF margin (%): -199.72586835471847
Revenue growth (%): -17.152556090424273
Rule of 40 score: -216.87842444514274
Financial ratios for DEFT — quarterly report dated 2025-12-31
Total revenue: -2903132.8467153283
Gross profit: -14958276.642335765
Operating income: 21254460.583941605
Net income: 21721298.540145982
Capital expenditures: 11463.503649635035
Operating cash flow: -14767117.518248174
Depreciation & amortization: 236307.29927007298
Net tangible assets: 83265292.70072992
Owner earnings: 21946142.335766423
Return on net tangible assets (%): 26.35689087726469
Capex to operating income (%): 0.05393457812943069
Buffett classification: The Great
Stock price: 0.75
P/E ratio: 6.514270742292051
Shares outstanding: 387895989
Book value: 109163396.35036498
P/B ratio: 2.665014111655819
Market cap (USD): 290921991.75
Debt to equity: 0.03820160353876004
Current ratio: 0.9887455853155894
Quick ratio: 0.9887455853155894
Effective tax rate (%): -1.2685478518575084
Interest coverage ratio: 6.769296845268856
Free cash flow (dilution-adjusted): -16545332.11678832
Buyback yield (%): 0.08147994047047859
Retained earnings: -73067068.61313868
Receivables turnover: -0.04162937271789242
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.14412564068491
Revenue growth (%): -117.74520623365443
Rule of 40 score: -117.74520623365443
Financial ratios for DEFT — annual report dated 2025-12-31
Total revenue: 55359032.84671532
Gross profit: 38970581.02189781
Operating income: 49603961.31386861
Net income: 45551625.54744525
Capital expenditures: 1140.875912408759
Operating cash flow: -97340728.46715328
Depreciation & amortization: 1124507.299270073
Net tangible assets: 83265292.70072992
Owner earnings: 46674991.97080292
Return on net tangible assets (%): 56.05575919676525
Capex to operating income (%): 0.0022999693617005244
Buffett classification: The Great
Stock price: 0.75
P/E ratio: 6.38664346779423
Shares outstanding: 387895989
Book value: 109163396.35036498
P/B ratio: 2.665014111655819
Market cap (USD): 290921991.75
Debt to equity: 0.03820160353876004
Current ratio: 0.9887455853155894
Quick ratio: 0.9887455853155894
Effective tax rate (%): 1.7904769992215404
Interest coverage ratio: 14.529749805596305
COGS to revenue (%): 29.60393450188303
SG&A to revenue (%): 39.59700363420604
Free cash flow (dilution-adjusted): -106984280.29197079
Buyback yield (%): 0.6949034671247984
Retained earnings: -73067068.61313868
Receivables turnover: 0.7938189305685394
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.67883171713352
FCF margin (%): -193.2553276141973
Revenue growth (%): 13.30673960905382
Rule of 40 score: -179.9485880051435
Financial ratios for DNA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 29076000
Buffett classification: The Gruesome
Stock price: 332.4
Shares outstanding: 53361141
Market cap (USD): 17737243268.399998
Buyback yield (%): 0.14093509133144433
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNA — annual report dated 2022-12-31
Total revenue: 477706000
Gross profit: 273490000
Operating income: -2208952000
Net income: -2104929000
Capital expenditures: 52271000
Operating cash flow: -252198000
Depreciation & amortization: 44423000
Net tangible assets: 1565026000
Owner earnings: -2112777000
Return on net tangible assets (%): -134.99948243671352
Buffett classification: The Gruesome
Stock price: 67.6
Shares outstanding: 53361141
Book value: 1736277000
P/B ratio: 2.0775562491468813
Market cap (USD): 3607213131.6
Debt to equity: 0.2549063311902421
Current ratio: 8.383801066130133
Quick ratio: 8.358570090540118
Interest coverage ratio: -20839.169811320753
COGS to revenue (%): 42.749306058538096
R&D to revenue (%): 220.35373221186254
SG&A to revenue (%): 299.3052212029993
Free cash flow (dilution-adjusted): -2235110000
Buyback yield (%): 0
Retained earnings: -4397659000
Inventory turnover: 46.795600366636116
Receivables turnover: 5.6852164806131436
Capitalized R&D asset: 1052643000
ROCI (R&D-adjusted, %): -44.082746953643195
FCF margin (%): -467.88401234231935
Rule of 40 score: -467.88401234231935
Financial ratios for DNA — annual report dated 2023-12-31
Total revenue: 251455000
Gross profit: 197450000
Operating income: -768196000
Net income: -892869000
Capital expenditures: 36373000
Operating cash flow: -295500000
Depreciation & amortization: 71554000
Net tangible assets: 965173000
Owner earnings: -857688000
Return on net tangible assets (%): -88.86365449510087
Buffett classification: The Gruesome
Stock price: 67.6
Shares outstanding: 53361141
Book value: 1097152000
P/B ratio: 3.287797070597328
Market cap (USD): 3607213131.6
Debt to equity: 0.21811836463862802
Current ratio: 6.113444403759306
Quick ratio: 6.1131636763090444
Interest coverage ratio: -8260.172043010753
COGS to revenue (%): 21.47700383766479
R&D to revenue (%): 230.90453560279175
SG&A to revenue (%): 153.11884830287724
Free cash flow (dilution-adjusted): -566185000
Buyback yield (%): 0
Retained earnings: -5290528000
Inventory turnover: 1174.0217391304348
Receivables turnover: 14.048550198335102
Capitalized R&D asset: 1285891810
ROCI (R&D-adjusted, %): -26.261146987433786
Rosenberg metric: -0.07223721622620395
FCF margin (%): -225.16354814976833
Revenue growth (%): -47.36197577589564
Rule of 40 score: -272.52552392566395
Financial ratios for DNA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.15
Shares outstanding: 53361141
Market cap (USD): 434893299.15000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNA — quarterly report dated 2024-12-31
Capital expenditures: 13710000
Buffett classification: The Gruesome
Stock price: 9.82
Shares outstanding: 53361141
Market cap (USD): 524006404.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNA — annual report dated 2024-12-31
Total revenue: 227043000
Gross profit: 182495000
Operating income: -487727000
Net income: -547029000
Capital expenditures: 61893000
Operating cash flow: -319585000
Depreciation & amortization: 63020000
Net tangible assets: 643548000
Owner earnings: -545902000
Return on net tangible assets (%): -84.82692821669868
Buffett classification: The Gruesome
Stock price: 9.82
Shares outstanding: 53361141
Book value: 716058000
P/B ratio: 0.7317932410782367
Market cap (USD): 524006404.62
Debt to equity: 0.6532026735264462
Current ratio: 5.6191523875226075
Quick ratio: 5.6191523875226075
Interest coverage ratio: -5188.585106382979
COGS to revenue (%): 19.62095285915003
R&D to revenue (%): 186.775632809644
SG&A to revenue (%): 108.42043137203086
Free cash flow (dilution-adjusted): -494470000
Buyback yield (%): 0
Retained earnings: -5837557000
Receivables turnover: 10.116428284988638
Capitalized R&D asset: 1160449260
ROCI (R&D-adjusted, %): -30.83317095445775
Rosenberg metric: -0.02575690510677361
FCF margin (%): -217.78693903797958
Revenue growth (%): -9.708297707343263
Rule of 40 score: -227.49523674532284
Financial ratios for DNA — quarterly report dated 2025-03-31
Total revenue: 38230000
Gross profit: 34140000
Operating income: -76506000
Net income: -90957000
Capital expenditures: 7622000
Operating cash flow: -51521000
Depreciation & amortization: 14822000
Net tangible assets: 578671000
Owner earnings: -83757000
Return on net tangible assets (%): -14.47402755624526
Buffett classification: The Gruesome
Stock price: 5.7
Shares outstanding: 53361141
Book value: 647427000
P/B ratio: 0.4697958282555408
Market cap (USD): 304158503.7
Debt to equity: 0.6712123528984735
Current ratio: 4.880683340970199
Quick ratio: 4.880683340970199
COGS to revenue (%): 10.698404394454617
R&D to revenue (%): 185.51660999215275
SG&A to revenue (%): 103.9053099659953
Free cash flow (dilution-adjusted): -76529000
Buyback yield (%): 0
Retained earnings: -5928514000
Receivables turnover: 1.4070666175929334
Capitalized R&D asset: 70923000
ROCI (R&D-adjusted, %): -2.3403183582535383
FCF margin (%): -200.180486528904
Rule of 40 score: -200.180486528904
Financial ratios for DNA — quarterly report dated 2025-06-30
Total revenue: 49604000
Gross profit: 34782000
Operating income: -61867000
Net income: -60300000
Capital expenditures: 38000
Operating cash flow: -40254000
Depreciation & amortization: 16337000
Net tangible assets: 546800000
Owner earnings: -44001000
Return on net tangible assets (%): -8.047000731528895
Buffett classification: The Gruesome
Stock price: 11.25
Shares outstanding: 53361141
Book value: 612952000
P/B ratio: 0.979379847443193
Market cap (USD): 600312836.25
Debt to equity: 0.6996094310810634
Current ratio: 5.407619933829611
Quick ratio: 5.407619933829611
COGS to revenue (%): 29.880654785904365
R&D to revenue (%): 107.59212966696235
SG&A to revenue (%): 87.24901217643738
Free cash flow (dilution-adjusted): -65584000
Buyback yield (%): 0
Retained earnings: -5988814000
Receivables turnover: 2.1449450834558506
Capitalized R&D asset: 100888410
ROCI (R&D-adjusted, %): -4.042172371011869
Rosenberg metric: 0.009052070555391058
FCF margin (%): -132.21514394000485
Revenue growth (%): 29.751504054407533
Rule of 40 score: -102.46363988559732
Financial ratios for DNA — quarterly report dated 2025-09-30
Total revenue: 38837000
Gross profit: 26035000
Operating income: -88272000
Net income: -80755000
Capital expenditures: 0
Operating cash flow: -31606000
Depreciation & amortization: 14168000
Net tangible assets: 498261000
Owner earnings: -66587000
Return on net tangible assets (%): -13.363879573155435
Buffett classification: The Gruesome
Stock price: 14.58
Shares outstanding: 53361141
Book value: 559783000
P/B ratio: 1.3898339817036245
Market cap (USD): 778005435.78
Debt to equity: 0.7554177243681927
Current ratio: 4.389986207614438
Quick ratio: 4.389986207614438
COGS to revenue (%): 32.963411180060255
R&D to revenue (%): 178.5745551922136
SG&A to revenue (%): 115.75044416407034
Free cash flow (dilution-adjusted): -49447000
Buyback yield (%): 0
Retained earnings: -6069569000
Receivables turnover: 1.7369739254886176
Capitalized R&D asset: 128515490
ROCI (R&D-adjusted, %): -6.941758322491193
Rosenberg metric: -0.1638935731684467
FCF margin (%): -127.31930890645518
Revenue growth (%): -21.70591081364406
Rule of 40 score: -149.02521972009924
Financial ratios for DNA — quarterly report dated 2025-12-31
Total revenue: 33396000
Gross profit: 26095000
Operating income: -70046000
Net income: -80751000
Capital expenditures: 569000
Operating cash flow: -47678000
Depreciation & amortization: 13663000
Net tangible assets: 451666000
Owner earnings: -67657000
Return on net tangible assets (%): -14.979431703958234
Buffett classification: The Gruesome
Stock price: 8.31
Shares outstanding: 53361141
Book value: 508590000
P/B ratio: 0.8718832098743586
Market cap (USD): 443431081.71000004
Debt to equity: 0.8649108319078236
Current ratio: 4.9165155777847245
Quick ratio: 4.9165155777847245
COGS to revenue (%): 21.861899628698048
R&D to revenue (%): 150.09881422924903
SG&A to revenue (%): 137.78296802012218
Free cash flow (dilution-adjusted): -68710000
Buyback yield (%): 0
Retained earnings: -6150320000
Receivables turnover: 1.3768707482993197
Capitalized R&D asset: 114205610
ROCI (R&D-adjusted, %): -6.813736957941317
Rosenberg metric: 0.0008651392153187317
FCF margin (%): -205.74320277877592
Revenue growth (%): -14.009835981151994
Rule of 40 score: -219.7530387599279
Financial ratios for DNA — annual report dated 2025-12-31
Total revenue: 170155000
Gross profit: 123183000
Operating income: -303880000
Net income: -312763000
Capital expenditures: 7091000
Operating cash flow: -171059000
Depreciation & amortization: 58990000
Net tangible assets: 451666000
Owner earnings: -260864000
Return on net tangible assets (%): -57.75595240730983
Buffett classification: The Gruesome
Stock price: 8.31
Shares outstanding: 53361141
Book value: 508590000
P/B ratio: 0.8718832098743586
Market cap (USD): 443431081.71000004
Debt to equity: 0.8649108319078236
Current ratio: 4.9165155777847245
Quick ratio: 4.9165155777847245
COGS to revenue (%): 27.605418588933617
R&D to revenue (%): 143.26525814698363
SG&A to revenue (%): 107.71943228233081
Free cash flow (dilution-adjusted): -260270000
Buyback yield (%): 0
Retained earnings: -6150320000
Receivables turnover: 7.015254586683158
Capitalized R&D asset: 719498800
ROCI (R&D-adjusted, %): -27.320553646705044
Rosenberg metric: -0.13986667012528858
FCF margin (%): -152.96053598189886
Revenue growth (%): -25.0560466519558
Rule of 40 score: -178.01658263385465
Financial ratios for DTE — annual report dated 2021-12-31
Capital expenditures: 3772000000
Buffett classification: The Gruesome
Stock price: 102.98
Shares outstanding: 208028313
Market cap (USD): 21422755672.74
Buyback yield (%): 0.30808361449028515
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTE — annual report dated 2022-12-31
Total revenue: 19228000000
Gross profit: 3668000000
Operating income: 1772000000
Net income: 1083000000
Capital expenditures: 3378000000
Operating cash flow: 1977000000
Depreciation & amortization: 1468000000
Net tangible assets: 8238000000
Owner earnings: -827000000
Return on net tangible assets (%): -10.03884437970381
Capex to operating income (%): 190.63205417607222
Buffett classification: The Gruesome
Stock price: 104.25
P/E ratio: 20.024886085180057
Shares outstanding: 208028313
Book value: 10401000000
P/B ratio: 2.0850833218200173
Market cap (USD): 21686951630.25
Debt to equity: 1.8498221324872608
Current ratio: 0.8080417552677364
Quick ratio: 0.6259423931954379
Effective tax rate (%): 2.6079136690647484
Interest coverage ratio: 2.625185185185185
COGS to revenue (%): 82.50468067401707
SG&A to revenue (%): -0.005200748907842729
Free cash flow (dilution-adjusted): -1401000000
Buyback yield (%): 0.25360871798728674
Retained earnings: 3808000000
Inventory turnover: 16.840764331210192
Receivables turnover: 8.812098991750688
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.724073580378565
FCF margin (%): -7.286249219887663
Rule of 40 score: -7.286249219887663
Financial ratios for DTE — annual report dated 2023-12-31
Total revenue: 12745000000
Gross profit: 4327000000
Operating income: 2301000000
Net income: 1397000000
Capital expenditures: 3934000000
Operating cash flow: 3220000000
Depreciation & amortization: 1606000000
Net tangible assets: 8901000000
Owner earnings: -931000000
Return on net tangible assets (%): -10.459498932704191
Capex to operating income (%): 170.96914385049976
Buffett classification: The Gruesome
Stock price: 101.31
P/E ratio: 15.086147738031496
Shares outstanding: 208028313
Book value: 11055000000
P/B ratio: 1.9064087191343284
Market cap (USD): 21075348390.03
Debt to equity: 1.8968792401628223
Current ratio: 0.6015638279789223
Quick ratio: 0.4224035356110828
Effective tax rate (%): 10.79182630906769
Interest coverage ratio: 2.90897597977244
COGS to revenue (%): 68.81129854845037
SG&A to revenue (%): 0.07061592781482935
Free cash flow (dilution-adjusted): -714000000
Buyback yield (%): 0
Retained earnings: 4404000000
Inventory turnover: 8.320683111954459
Receivables turnover: 7.132064913262451
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.9194278658160115
FCF margin (%): -5.602196939976461
Revenue growth (%): -33.71645516954441
Rule of 40 score: -39.31865210952087
Financial ratios for DTE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 121.18
Shares outstanding: 208028313
Market cap (USD): 25208870969.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTE — annual report dated 2024-12-31
Total revenue: 12457000000
Gross profit: 4338000000
Operating income: 2205000000
Net income: 1404000000
Capital expenditures: 4467000000
Operating cash flow: 3643000000
Depreciation & amortization: 1732000000
Net tangible assets: 9562000000
Owner earnings: -1331000000
Return on net tangible assets (%): -13.919682074879733
Capex to operating income (%): 202.58503401360545
Buffett classification: The Gruesome
Stock price: 114.98
P/E ratio: 17.03639275551282
Shares outstanding: 208028313
Book value: 11704000000
P/B ratio: 2.0436684405963774
Market cap (USD): 23919095428.74
Debt to equity: 1.9857313738892686
Current ratio: 0.7064238151194673
Quick ratio: 0.4625930278104191
Effective tax rate (%): -2.4817518248175183
Interest coverage ratio: 2.3186119873817033
COGS to revenue (%): 68.38725214738702
Free cash flow (dilution-adjusted): -824000000
Buyback yield (%): 0
Retained earnings: 4946000000
Inventory turnover: 6.842570281124498
Receivables turnover: 6.818281335522715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.041152263374485
FCF margin (%): -6.614754756361885
Revenue growth (%): -2.2597096900745393
Rule of 40 score: -8.874464446436424
Financial ratios for DTE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 114.98
Shares outstanding: 208028313
Market cap (USD): 23919095428.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DTE — quarterly report dated 2025-03-31
Total revenue: 4440000000
Gross profit: 1213000000
Operating income: 623000000
Net income: 445000000
Capital expenditures: 873000000
Operating cash flow: 1020000000
Depreciation & amortization: 452000000
Net tangible assets: 9787000000
Owner earnings: 24000000
Return on net tangible assets (%): 0.24522325533871464
Capex to operating income (%): 140.12841091492777
Buffett classification: The Gruesome
Stock price: 132.74
P/E ratio: 15.513302397539327
Shares outstanding: 208028313
Book value: 11927000000
P/B ratio: 2.3152241357944163
Market cap (USD): 27613678267.620003
Debt to equity: 1.9650373103043515
Current ratio: 0.8711464354527938
Quick ratio: 0.5929672447013488
Effective tax rate (%): -4.215456674473068
Interest coverage ratio: 2.492
COGS to revenue (%): 72.68018018018017
Free cash flow (dilution-adjusted): 147000000
Buyback yield (%): 0
Retained earnings: 5163000000
Inventory turnover: 2.793939393939394
Receivables turnover: 2.3516949152542375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.372156024932273
FCF margin (%): 3.310810810810811
Rule of 40 score: 3.310810810810811
Financial ratios for DTE — quarterly report dated 2025-06-30
Total revenue: 3419000000
Gross profit: 1004000000
Operating income: 448000000
Net income: 229000000
Capital expenditures: 971000000
Operating cash flow: 709000000
Depreciation & amortization: 484000000
Net tangible assets: 9592000000
Owner earnings: -258000000
Return on net tangible assets (%): -2.689741451209341
Capex to operating income (%): 216.74107142857144
Buffett classification: The Gruesome
Stock price: 128.19
P/E ratio: 39.56550362532641
Shares outstanding: 208028313
Book value: 11727000000
P/B ratio: 2.273995859424405
Market cap (USD): 26667149443.47
Debt to equity: 2.0458770359000598
Current ratio: 0.936491135220958
Quick ratio: 0.5739613654405927
Effective tax rate (%): 0.43478260869565216
Interest coverage ratio: 1.75
COGS to revenue (%): 70.63468850541094
Free cash flow (dilution-adjusted): -262000000
Buyback yield (%): 0
Retained earnings: 4940000000
Inventory turnover: 1.7627737226277371
Receivables turnover: 1.9437180216031835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9640835826034561
FCF margin (%): -7.663059374085989
Revenue growth (%): -22.995495495495497
Rule of 40 score: -30.658554869581486
Financial ratios for DTE — quarterly report dated 2025-09-30
Total revenue: 3527000000
Gross profit: 1267000000
Operating income: 669000000
Net income: 419000000
Capital expenditures: 1222000000
Operating cash flow: 632000000
Depreciation & amortization: 464000000
Net tangible assets: 9975000000
Owner earnings: -339000000
Return on net tangible assets (%): -3.3984962406015033
Capex to operating income (%): 182.66068759342303
Buffett classification: The Gruesome
Stock price: 137.97
P/E ratio: 26.259530049963402
Shares outstanding: 208028313
Book value: 12163000000
P/B ratio: 2.359752227625586
Market cap (USD): 28701666344.61
Debt to equity: 2.079750061662419
Current ratio: 1.1518677281077772
Quick ratio: 0.6763625229638702
Effective tax rate (%): -1.4527845036319613
Interest coverage ratio: 2.4686346863468636
COGS to revenue (%): 65.0127587184576
Free cash flow (dilution-adjusted): -590000000
Buyback yield (%): 0
Retained earnings: 5357000000
Inventory turnover: 1.4764971023824855
Receivables turnover: 2.229456384323641
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3719699766211395
FCF margin (%): -16.728097533314433
Revenue growth (%): 3.1588183679438435
Rule of 40 score: -13.569279165370588
Financial ratios for DTE — quarterly report dated 2025-12-31
Total revenue: 4428000000
Gross profit: 1309000000
Operating income: 810000000
Net income: 369000000
Capital expenditures: 1363000000
Operating cash flow: 1048000000
Depreciation & amortization: 474000000
Net tangible assets: 10122000000
Owner earnings: -520000000
Return on net tangible assets (%): -5.137324639399328
Capex to operating income (%): 168.2716049382716
Buffett classification: The Gruesome
Stock price: 126.96
P/E ratio: 18.06516731770178
Shares outstanding: 208028313
Book value: 12308000000
P/B ratio: 2.145862416191095
Market cap (USD): 26411274618.48
Debt to equity: 2.136009099772506
Current ratio: 0.8038454427805509
Quick ratio: 0.5496394897393233
Effective tax rate (%): 23.125
Interest coverage ratio: 2.903225806451613
COGS to revenue (%): 83.0397470641373
Free cash flow (dilution-adjusted): -315000000
Buyback yield (%): 0
Retained earnings: 5484000000
Inventory turnover: 2.674181818181818
Receivables turnover: 2.060493252675663
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6647142240582034
FCF margin (%): -7.113821138211382
Revenue growth (%): 25.545789622908988
Rule of 40 score: 18.431968484697606
Financial ratios for DTE — annual report dated 2025-12-31
Total revenue: 15814000000
Gross profit: 4793000000
Operating income: 2528000000
Net income: 1462000000
Capital expenditures: 4429000000
Operating cash flow: 3409000000
Depreciation & amortization: 1841000000
Net tangible assets: 10122000000
Owner earnings: -1126000000
Return on net tangible assets (%): -11.124283738391622
Capex to operating income (%): 175.19778481012656
Buffett classification: The Gruesome
Stock price: 126.96
P/E ratio: 18.06516731770178
Shares outstanding: 208028313
Book value: 12308000000
P/B ratio: 2.145862416191095
Market cap (USD): 26411274618.48
Debt to equity: 2.136009099772506
Current ratio: 0.8038454427805509
Quick ratio: 0.5496394897393233
Effective tax rate (%): 5.67741935483871
Interest coverage ratio: 2.393939393939394
COGS to revenue (%): 73.21993170608322
Free cash flow (dilution-adjusted): -1020000000
Buyback yield (%): 0
Retained earnings: 5484000000
Inventory turnover: 8.421090909090909
Receivables turnover: 7.358771521637971
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.195552541258195
FCF margin (%): -6.449981029467561
Revenue growth (%): 26.948703540178215
Rule of 40 score: 20.498722510710653
Financial ratios for EGO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.33
Shares outstanding: 260535930
Market cap (USD): 2430800226.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGO — annual report dated 2022-12-31
Total revenue: 640780147.0588235
Gross profit: 126242647.05882353
Operating income: 45554411.76470588
Net income: -260164705.88235292
Capital expenditures: 209970588.2352941
Operating cash flow: 155144117.6470588
Depreciation & amortization: 178230147.05882353
Net tangible assets: 2287850735.2941175
Owner earnings: -291905147.05882347
Return on net tangible assets (%): -12.758924459348403
Capex to operating income (%): 460.9226200083933
Buffett classification: The Gruesome
Stock price: 8.35
Shares outstanding: 260535930
Book value: 2353579411.7647057
P/B ratio: 0.9243261581171108
Market cap (USD): 2175475015.5
Debt to equity: 0.16090354241412017
Current ratio: 2.9982696583404835
Quick ratio: 2.0554847089944577
Effective tax rate (%): 516.3967611336031
Interest coverage ratio: 1.7592571558382555
COGS to revenue (%): 80.2986020028435
SG&A to revenue (%): 6.166770515261153
Free cash flow (dilution-adjusted): -65883088.23529411
Buyback yield (%): 0.47214164521448465
Retained earnings: -1906654411.7647057
Inventory turnover: 3.5187004706544913
Receivables turnover: 13.00008950548221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4587794842211221
FCF margin (%): -10.281699353155219
Rule of 40 score: -10.281699353155219
Financial ratios for EGO — annual report dated 2023-12-31
Total revenue: 765226515.1515151
Gross profit: 204594696.96969697
Operating income: 131087121.2121212
Net income: 79265151.51515152
Capital expenditures: 303199242.42424244
Operating cash flow: 290387121.2121212
Depreciation & amortization: 200246212.12121212
Net tangible assets: 2595118181.8181815
Owner earnings: -23687878.78787881
Return on net tangible assets (%): -0.9127861287335556
Capex to operating income (%): 231.29598058196322
Buffett classification: The Gruesome
Stock price: 12.95
P/E ratio: 42.565241206346165
Shares outstanding: 260535930
Book value: 2660579545.4545455
P/B ratio: 1.2681223154046237
Market cap (USD): 3373940293.5
Debt to equity: 0.18758899932089299
Current ratio: 3.3929799609795235
Quick ratio: 2.532742556023558
Effective tax rate (%): 35.24316714106449
Interest coverage ratio: 5.671976923329072
COGS to revenue (%): 73.26351179438846
SG&A to revenue (%): 5.366899680130363
Free cash flow (dilution-adjusted): -29951515.15151515
Buyback yield (%): 0.09973950996212302
Retained earnings: -1885166666.6666665
Inventory turnover: 3.137199542159481
Receivables turnover: 9.992570608893505
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6711143227453364
FCF margin (%): -3.91407178900286
Revenue growth (%): 19.421071121491458
Rule of 40 score: 15.506999332488599
Financial ratios for EGO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.34
Shares outstanding: 260535930
Market cap (USD): 4517693026.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.85
Shares outstanding: 260535930
Market cap (USD): 3868958560.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGO — annual report dated 2024-12-31
Total revenue: 925550349.6503497
Gross profit: 355195104.8951049
Operating income: 291123776.2237762
Net income: 202182517.48251748
Capital expenditures: 411174825.1748252
Operating cash flow: 458469230.7692308
Depreciation & amortization: 178315384.6153846
Net tangible assets: 2660139160.839161
Owner earnings: -30676923.076923132
Return on net tangible assets (%): -1.153207453524569
Capex to operating income (%): 141.23711587842627
Buffett classification: The Gruesome
Stock price: 14.85
P/E ratio: 19.13596985869238
Shares outstanding: 260535930
Book value: 2719193706.2937064
P/B ratio: 1.4228330080145106
Market cap (USD): 3868958560.5
Debt to equity: 0.24115617366007563
Current ratio: 3.59590367175028
Quick ratio: 2.9190172111778034
Effective tax rate (%): 30.950816961189176
Interest coverage ratio: 20.6912027833002
COGS to revenue (%): 61.62336224827866
SG&A to revenue (%): 3.905897606187058
Free cash flow (dilution-adjusted): 13381818.181818184
Buyback yield (%): 0.03546246232863915
Retained earnings: -1533680419.5804195
Inventory turnover: 2.9233785551712392
Receivables turnover: 10.128386237717715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.676098785655322
FCF margin (%): 1.4458228217269333
Revenue growth (%): 20.951160385116875
Rule of 40 score: 22.396983206843807